Acquisition by Kyle Guse of 495333 shares of Atossa Genetics at 0.47 subject to Rule 16b-3
| ATOS Stock | USD 1.27 0.03 2.31% |
Slightly above 61% of Atossa Genetics' investor base is looking to short. The analysis of overall sentiment of trading Atossa Genetics stock suggests that many investors are alarmed at this time. Atossa Genetics' investing sentiment can be driven by a variety of factors including economic data, Atossa Genetics' earnings reports, geopolitical events, and overall market trends.
Atossa |
Filed transaction by Atossa Genetics Officer Cfo, Gen Counsel And Secretary. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Atossa Genetics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Atossa Genetics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Atossa Genetics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Atossa Genetics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Atossa Genetics Fundamental Analysis
We analyze Atossa Genetics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atossa Genetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atossa Genetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Atossa Genetics is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Atossa Genetics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Atossa Genetics stock to make a market-neutral strategy. Peer analysis of Atossa Genetics could also be used in its relative valuation, which is a method of valuing Atossa Genetics by comparing valuation metrics with similar companies.
Peers
Atossa Genetics Related Equities
| ENVB | Enveric Biosciences | 3.13 | ||||
| SONN | Sonnet Biotherapeutics | 1.56 | ||||
| OCEA | Ocean Biomedical | 1.43 | ||||
| INO | Inovio Pharmaceuticals | 0.69 | ||||
| NVAX | Novavax | 0.57 | ||||
| TNXP | Tonix Pharmaceuticals | 0.00 | ||||
| VXRT | Vaxart | 1.67 | ||||
| JAGX | Jaguar Animal | 1.92 | ||||
| PALI | Palisade Bio | 2.44 | ||||
| ELEV | Elevation Oncology | 3.13 | ||||
| OCGN | Ocugen | 4.08 | ||||
| IBIO | Ibio | 4.76 | ||||
| GOVX | GeoVax Labs | 4.92 |
Additional Tools for Atossa Stock Analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.